Indaptus Therapeutics (INDP) Deferred Taxes (2021)
Indaptus Therapeutics (INDP) posted quarterly Deferred Taxes of -$268848.0 for Q2 2021, up 55.56% quarter-over-quarter from -$604988.0 in Q1 2021.
Indaptus Therapeutics (INDP) Deferred Taxes (2021) Analysis & Trends
Indaptus Therapeutics' Deferred Taxes history runs 1 years deep, the most recent figure standing at -$268848.0 for Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Indaptus Therapeutics | 145.16 Mn | 133.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -268,848.00 |
| Mar 31, 2021 | -604,988.00 |